Literature DB >> 29533350

Amikacin Monotherapy for Treatment of Febrile Urinary Tract Infection Caused by Extended-Spectrum β-Lactamase-producing Escherichia coli in Children.

Meltem Polat1, Anil Tapisiz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29533350     DOI： 10.1097/INF.0000000000001860

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  2 in total

1.  The Emerging Resistance in Nosocomial Urinary Tract Infections: From the Pediatrics Perspective.

Authors:  Fatma Devrim; Erkin Serdaroğlu; İlknur Çağlar; Yeliz Oruç; Nevbahar Demiray; Nuri Bayram; Hasan Ağın; Sebnem Çalkavur; Yelda Sorguç; Nida Dinçel; Yüce Ayhan; Ebru Yılmaz; Ilker Devrim
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-09-01       Impact factor: 2.576

2.  Amikacin-loaded niosome nanoparticles improve amikacin activity against antibiotic-resistant Klebsiella pneumoniae strains.

Authors:  Mohamad Rahmati; Ebrahim Babapoor; Mehrouz Dezfulian
Journal:  World J Microbiol Biotechnol       Date:  2022-10-03       Impact factor: 4.253
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.